| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.762 | 91.283 | 117.140 | 141.117 | 231.514 | 399.451 | 588.450 | 414.032 | 341.057 | 364.593 |
| Total Income - EUR | 70.924 | 91.283 | 117.140 | 141.138 | 232.278 | 399.467 | 588.805 | 414.080 | 341.098 | 367.536 |
| Total Expenses - EUR | 68.229 | 85.345 | 116.982 | 134.599 | 182.903 | 241.090 | 303.883 | 408.601 | 337.379 | 390.616 |
| Gross Profit/Loss - EUR | 2.695 | 5.938 | 158 | 6.540 | 49.375 | 158.377 | 284.922 | 5.478 | 3.719 | -23.080 |
| Net Profit/Loss - EUR | 2.695 | 5.025 | -1.013 | 5.128 | 47.053 | 154.383 | 279.037 | 1.703 | 308 | -34.106 |
| Employees | 5 | 9 | 18 | 10 | 27 | 22 | 33 | 23 | 29 | 21 |
Check the financial reports for the company - Apel One Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.394 | 17.027 | 10.570 | 11.790 | 43.751 | 31.207 | 96.612 | 169.204 | 150.409 | 128.695 |
| Current Assets | 10.422 | 7.823 | 14.804 | 41.308 | 45.883 | 257.735 | 318.193 | 308.507 | 323.052 | 303.894 |
| Inventories | 724 | 1.075 | 2.531 | 2.760 | 0 | 0 | 0 | 0 | 0 | 27.954 |
| Receivables | 9.527 | 5.989 | 11.427 | 37.918 | 36.711 | 182.881 | 290.418 | 288.060 | 322.922 | 274.486 |
| Cash | 171 | 759 | 846 | 630 | 9.172 | 74.853 | 27.775 | 20.447 | 130 | 1.454 |
| Shareholders Funds | -41.355 | -35.886 | -36.270 | -30.476 | 17.167 | 171.224 | 301.320 | 173.944 | 161.090 | 126.084 |
| Social Capital | 225 | 245 | 263 | 258 | 253 | 248 | 243 | 243 | 243 | 241 |
| Debts | 62.170 | 60.736 | 61.645 | 83.574 | 72.467 | 117.718 | 113.485 | 303.767 | 312.371 | 306.506 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Apel One Med Srl